GroundRules
← Search the law
Federal regulations · Through 2026-08-25 · Newer source version available

21 CFR 866.5765: Retinol-binding protein immunological test system.

Read at publisher ↗
Where this section sits in the code
  1. Title 21—Food and Drugs
  2. CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES
  3. SUBCHAPTER H—MEDICAL DEVICES
  4. PART 866—IMMUNOLOGY AND MICROBIOLOGY DEVICES
  5. Subpart F—Immunological Test Systems

(a) Identification. A retinol-binding protein immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the retinol-binding protein that binds and transports vitamin A in serum and urine. Measurement of this protein may aid in the diagnosis of kidney disease and in monitoring patients with kidney transplants.

(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

Collected 2026-08-27T02:24:47Z. Source file · JSON

Browse this collection